STRS Ohio’s Marker Therapeutics MRKR Stock Holding History

STRS Ohio’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-720	Closed	-$57K	–	2119
2019 Q2	$57K	Buy	+720	New	+$42.8K	﹤0.01%	1903

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

STRS Ohio's MRKR Position: Q3 2019 in Review

STRS Ohio sold out of Marker Therapeutics (MRKR) in Q3 2019, closing a stake of 720 shares — an estimated $57K sold.

STRS Ohio first reported a position in MRKR in Q2 2019 and held it in 1 quarter. The position peaked at $57K in Q2 2019. 73 funds tracked by Wall St. Rank hold MRKR as of Q3 2019.

STRS Ohio reported no remaining Marker Therapeutics position as of Q3 2019 after selling out during the quarter.
STRS Ohio sold 720 Marker Therapeutics shares in Q3 2019, an estimated $57K.
STRS Ohio first reported a position in Marker Therapeutics in Q2 2019 and held it in 1 quarter.
STRS Ohio's Marker Therapeutics position peaked at $57K in Q2 2019.
73 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2019.

Based on STRS Ohio's 13F filing for Q3 2019, filed 21 Oct 2019.